Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional ...
New research suggests combining antiviral medicines with immune-based therapies could bring scientists closer to a functional ...
The payment gives Aligos non-dilutive funding as it advances its pipeline of treatments for liver and viral diseases.
In patients with chronic hepatitis B infection, bepirovirsen achieves significantly higher rates of functional cure than placebo after discontinuation of nucleoside or nucleotide analog therapy.
FILE - This 1981 electron microscope image made available by the U.S. Centers for Disease Control and Prevention shows hepatitis B virus particles, indicated in orange. (Dr. Erskine Palmer/CDC via AP, ...
Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, ...
Add Yahoo as a preferred source to see more of our stories on Google. Hepatitis B is a serious liver infection spread through contact with blood or other bodily fluids. - Dr. Erskine Palmer/CDC/AP A ...
WASHINGTON (AP) — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers ...
WASHINGTON — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results